Skip to content
healthcare.dev

Deferasirox

NDC 69539-075, Deferasirox, tablet, from MSN LABORATORIES PRIVATE LIMITED.

Product NDC
69539-075
Status
Listed
Labeler
MSN LABORATORIES PRIVATE LIMITED
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210945
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69539-075 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX360 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
69539-075-306953900753030 TABLET in 1 BOTTLE (69539-075-30)
69539-075-99695390075991000 TABLET in 1 BOTTLE (69539-075-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0354cbc7-9b32-4513-976a-2ef2da39b6b3

Use it

Look up 69539-075 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69539-075 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69539-075. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.